Overview
Status
Active
Registry date
2024-01-12
Share capital
100 000,00 PLN
Registered address
ul. Basztowa 13, 37-700 Przemyśl, Poland
Email
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 61 days early.
- 202516/04/2026
- 202413/06/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 106.47kMedianUSD 1.06mAverageUSD 22.39m
Net profit
This companyUSD 14.96kMedianUSD 36.98kAverageUSD 878.93k
Operating costs
This companyUSD 89.51kMedianUSD 921.42kAverageUSD 21.07m
Assets
This companyUSD 57.42kMedianUSD 607.52kAverageUSD 11.85m
Industry
Authorized Representatives
Andrii Lozynskyi – Attorney-in-fact
Andriy Khalil – Management Board Member
Volodymyr Duhanyak – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Oksana Duhanyakage 44 | 100 | $2,701.24 | 10% |
Volodymyr Duhanyakage 44 | 450 | $12,155.59 | 45% |
Andriy Khalilage 46 | 450 | $12,155.59 | 45% |
Volodymyr Duhanyak and Oksana Duhanyak hold a combined 55% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-01-24.
26 1020 4274 0000 1702 0105 1499
66 1020 4274 0000 1602 0105 1507
81 1020 4274 0000 1302 0105 1481
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Chde PolskaS.A. | $17,544,214.35 | chde.pl | ||
| MED Partner Marszałeksp. k. | $5,739,702.56 | med-partner.pl | ||
| Pharmbiopolsp. z o.o. | $99,211.10 | pharmbiopol.com | ||
| Mimic Polandsp. z o.o. | $85,589.70 | mimic.com.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| Toto Pharma Polandsp. z o.o. | $66,269.14 | totopharma.com | ||
| Polidental Tradesp. z o.o. | $9,409.06 | poli.dental | ||
| BIATsp. z o.o. | $2,327.20 | biat.pl | ||
| Hempire Hempsp. z o.o. | – | hempire.pl | ||
| Hempiresp. z o.o. | – | hempire.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-06-17 | Share capital change (10,000.00 PLN → 100,000.00 PLN) | |
| 2024-01-12 | Entered in the register |
FAQ
The main business activity of Polidental focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on January 12, 2024.
The headquarters is located at: ul. Basztowa 13, 37-700 Przemyśl.
The management board consists of: Andriy Khalil (Member of the Management Board) and Volodymyr Duhanyak (President of the Management Board).
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $106,468 in 2025, which is an increase of 11.7% compared to 2024.
Yes, the company recorded a net profit of $14,961 in 2025, meaning the company decreased its profit by 8.7%.
The largest operating cost category falls under other operating costs. This category amounted to $89,332 in 2025, representing 100% of all operating expenses.
Last updated: 2026-04-16